查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球體外毒理學測試市場 2023-2030
市場調查報告書
商品編碼
1380468

全球體外毒理學測試市場 2023-2030

Global In-Vitro Toxicology Testing Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 200 Pages | 商品交期: 2-3個工作天內

價格

預計全球體外毒理學測試市場在預測期內將以 10.5% 的CAGR成長。藥物研究支出的大幅成長是推動體外毒理學測試成長的關鍵因素。由於製藥公司研發支出增加以及進入臨床前開發階段的新藥數量增加，體外毒理學測試的需求也隨之增加。臨床前管道產能的顯著增加以及人們對體外測試服務優勢的認知不斷增強，正在推動全球市場的成長。此外，動物試驗傳統上不斷上漲的成本及其社會倫理問題進一步促進了市場的成長。用於評估藥物安全性的體外測試方法的重大發展以及這些藥物對細胞和組織的潛在影響是市場成長的其他一些貢獻者。

為了滿足不斷成長的需求，主要參與者正在開設或投資新設施。例如，2023 年 4 月，製藥和營養輔料供應商羅蓋特 (Roquette) 在費城附近開設了新的製藥創新中心。這個耗資 2,500 萬美元的新中心將成為全球製藥和營養保健品製造商的高級培訓和合作中心。美國設施專注於最佳化下一代口服劑型的患者體驗，補充了羅蓋特在法國和新加坡現有的製藥創新中心的尖端研究活動。支持這些培訓課程和該中心主要研究項目的是一套最新的製藥加工、測試和製造設備。

目錄

第 1 章：報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 按細分
    • 按地區

第 2 章：市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第 3 章：競爭格局

  • 主要公司分析
  • Abbott Laboratories
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Bio-Rad Laboratories
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Agilent Technologies Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第 4 章：市場細分

  • 按技術分類的全球體外毒理學測試市場
    • 細胞培養
    • 高吞吐量
    • 分子影像
    • 組學分析
  • 全球體外毒理學測試市場（依方法）
    • 細胞分析
    • 生化檢測
    • 二氧化矽中
    • 離體
  • 全球體外毒理學測試市場（按應用）
    • 系統毒理學
    • 皮膚毒性
    • 內分泌干擾
    • 眼部毒性
    • 其他應用
  • 全球體外毒理學測試市場（按最終用戶）
    • 製藥與生物技術
    • 診斷
    • 其他最終用戶

第 5 章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第 6 章：公司簡介

  • Abbott Laboratories
  • Agilent Technolgies, Inc.
  • BioIVT
  • Bio-Rad Laboratories, Inc.
  • Catalent, Inc.
  • Charles River Laboratories International, Inc.
  • Danaher Corp.
  • Eurofins Scientific
  • Evotec S.E.
  • Gentronix
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • Quest Diagnostics Inc.
  • SGS S.A.
  • Thermo Fisher Scientific, Inc.
Product Code: OMR2027767

Title: Global In-vitro toxicology testing Market Size, Share & Trends Analysis Report, by Technology (Cell Culture, High Throughput, Molecular Imaging, OMICS), by Method (Cellular Assay, Biochemical Assay, In Silica, Ex Vivo), by Application (Systematic Toxicology, Dermal Toxicity, Endocrine Disruption, Ocular Toxicity, Other Applications), by End-User (Pharmaceutical and Biotechnology, Diagnostics, Other End-Users)Forecast Period (2023-2030).

The global in-vitro toxicology testing market is anticipated to grow at a considerable CAGR of 10.5% during the forecast period. A considerable rise in pharmaceutical research expenditure is a key factor driving the growth of the in-vitro toxicology testing. Due to increased R&D expenditure by pharmaceutical companies as well as an increase in the number of novel medications entering the preclinical stage of development, there has also been an increase in demand for in-vitro toxicology testing. A significant increase in preclinical pipeline capacity along with growing awareness about the benefits of in-vitro testing services is driving the global market growth. In addition, the traditional rising cost of animal tests as well as their socio-ethical problems is further contributing to the market growth. Significant developments in the in-vitro testing assays used to evaluate the security of medicines and the potential impacts of those drugs on cells and tissues are some other contributors to the market growth.

To meet the growing demand key players are opening or investing new facilities. For instance, in April 2023, Roquette, a provider of pharmaceutical and nutraceutical excipients, opened its new pharmaceutical innovation center near Philadelphia. The new $25 million center will be an advanced training and collaboration hub for pharmaceutical and nutraceutical manufacturers across the globe. With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette's existing pharma innovation centers in France and Singapore. Underpinning these training sessions and the center's primary research projects is a suite of the latest pharmaceutical processing, testing, and manufacturing equipment.

In the same month, Millipore Sigma has invested $37.5 million to strengthen biosafety testing in Scotland. The investment includes a new 1200-m2 facility in Glasgow that will house molecular biology and sequencing services, and the company will add biosafety testing, analytical development, and viral clearance suites in its current buildings to expand testing capacity.

Segmental Outlook

The global in-vitro toxicology testing market is segmented based on technology, method, application, and end-user. Based on technology, the market is segmented into in cell culture, high throughput, molecular imaging, and OMICS. Based on method, the market is sub-segmented into cellular assay, biochemical assay, in silica, and ex vivo. Based on application, the market is sub-segmented into systematic toxicology, dermal toxicity, endocrine disruption, ocular toxicity, and other applications. Based on end-user, the market is sub-segmented into pharmaceutical and biotechnology, diagnostics, and other end-users.

Cell Culture Holds a Prominent Market Share in the Global In-vitro toxicology testing Market

The cell culture technology segment held considerable share in 2022. The cell cultures provide reproducible results to consistent samples, and serve as excellent models for toxicology assays. Hence, it is highly adopted to perform toxicology testing. This technology further enables early stage drug toxicity testing due to which this technology is gaining popularity & extensive application across the globe.

Regional Outlook

The global in-vitro toxicology testing market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America). Asia-Pacific is anticipated to exhibit highest CAGR in the global in-vitro toxicology testing market. The rising investment by companies from emerging economies in enhancing regional healthcare is a key promoter to the regional market growth. Establishment of new healthcare facilities along with alliances formation with major laboratories is further contributing to the market growth.

North America held Considerable Share in the Global In-Vitro Toxicology Testing Market

North America held considerable share in in-vitro toxicology testing market in 2022. The regional market is driven by the presence of key in-vitro toxicology testing service providers. The rising investments in R&D for the development of novel therapeutics for chronic diseases are further contributing to the market growth. According to EFPIA member associations in 2020, the US has invested $72,412 million in pharmaceutical R&D. Besides, the region has a relatively high disposable income, which enables people to afford expensive drugs and medical treatments. This creates a strong demand for pharmaceutical products in the region; which is further contributing to the regional market growth.

Market Players Outlook

The major companies serving the global in-vitro toxicology testing market include: Abbott Laboratories, Bio-Rad Laboratories, Laboratory Corporation of America Holdings, Agilent Technologies Inc., and Eurofins Scientific SE among others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global in-vitro toxicology testing market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Abbott Laboratories
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Bio-Rad Laboratories
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Agilent Technologies Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global In-vitro Toxicology Testing Market by Technology
    • 4.1.1. Cell Culture
    • 4.1.2. High Throughput
    • 4.1.3. Molecular Imaging
    • 4.1.4. OMICS
  • 4.2. Global In-vitro Toxicology Testing Markey by Method
    • 4.2.1. Cellular Assay
    • 4.2.2. Biochemical Assay
    • 4.2.3. In Silica
    • 4.2.4. Ex Vivo
  • 4.3. Global In-vitro Toxicology Testing Market by Application
    • 4.3.1. Systematic Toxicology
    • 4.3.2. Dermal Toxicity
    • 4.3.3. Endorine Disruption
    • 4.3.4. Occular Toxicity
    • 4.3.5. Other Applications
  • 4.4. Global In-vitro Toxicology Testing Market by End-User
    • 4.4.1. Pharmaceutical and Biotechnology
    • 4.4.2. Diagnostics
    • 4.4.3. Other End-Users

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Abbott Laboratories
  • 6.2. Agilent Technolgies, Inc.
  • 6.3. BioIVT
  • 6.4. Bio-Rad Laboratories, Inc.
  • 6.5. Catalent, Inc.
  • 6.6. Charles River Laboratories International, Inc.
  • 6.7. Danaher Corp.
  • 6.8. Eurofins Scientific
  • 6.9. Evotec S.E.
  • 6.10. Gentronix
  • 6.11. Laboratory Corporation of America Holdings
  • 6.12. Merck KGaA
  • 6.13. Quest Diagnostics Inc.
  • 6.14. SGS S.A.
  • 6.15. Thermo Fisher Scientific, Inc.

LIST OF TABLES

  • 1. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 2. GLOBAL CELL CULTURE BASED IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 3. GLOBAL HIGH THROUGHPUT BASED IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL MOLECULAR IMAGING BASED IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL OMICS BASED IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY METHOD, 2022-2030 ($ MILLION)
  • 7. GLOBAL CELLULAR ASSAY BASED IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 8. GLOBAL BIOCHEMICAL ASSAY BASED IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 9. GLOBAL IN SILICA BASED IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 10. GLOBAL EX VIVO BASED IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 11. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 12. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR SYSTEMATIC TOXICOLOGY MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 13. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR DERMAL TOXICITY MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 14. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR ENDOCRINE DISRUPTION MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 15. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR OCCULAR TOXICITY MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 16. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR OTHER APPLICATION MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 17. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 18. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR PHARMACEUTICAL AND BIOTECHNOLOGY MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 19. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 20. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR OTHER END-USER MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 21. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 22. NORTH AMERICAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. NORTH AMERICAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 24. NORTH AMERICAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY METHOD, 2022-2030 ($ MILLION)
  • 25. NORTH AMERICAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 26. NORTH AMERICAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 27. EUROPEAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 28. EUROPEAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 29. EUROPEAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY METHOD, 2022-2030 ($ MILLION)
  • 30. EUROPEAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 31. EUROPEAN IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 32. ASIA- PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 33. ASIA- PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 34. ASIA- PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY METHOD, 2022-2030 ($ MILLION)
  • 35. ASIA- PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 36. ASIA- PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 37. REST OF THE WORLD IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 38. REST OF THE WORLD IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 39. REST OF THE WORLD IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 40. REST OF THE WORLD IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY TECHNOLOGY, 2022 VS 2030 (%)
  • 2. GLOBAL CELL CULTURE BASED IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL HIGH THROUGHPUT BASED IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL MOLECULAR IMAGING BASED IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL OMICS BASED IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL EX VIVO IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY METHOD, 2022 VS 2030 ($ MILLION)
  • 8. GLOBAL CELLULAR ASSAY BASED IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL BIOCHEMICAL ASSAY BASED IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL IN SILICA BASED IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL EX VIVO BASED IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SHARE ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 13. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR SYSTEMATIC TOXICOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR DERMAL TOXICITY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR ENDOCRINE DISRUPTION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 16. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR OCCULAR TOXICITY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 17. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR OTHER APPLICATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 18. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SHARE ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 19. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR PHARMACEUTICAL AND BIOTECHNOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 20. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR VETERINARY HOSPITAL MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 21. GLOBAL IN-VITRO TOXICOLOGY TESTING FOR EX VIVO END-USER MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 22. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 23. US IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. UK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. SPAIN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. REST OF EUROPE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 31. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 32. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 33. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 34. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 35. REST OF ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 36. REST OF THE WORLD IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2022-2030 ($ MILLION)